Moolec Science SA Ordinary Shares (MLEC)

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Buffett-and-Graham-style investor, I see Moolec Science as a very small, pre-profit ingredient company. It uses molecular farming and precision fermentation to make ingredients for food, pet food, feed, and supplements. The latest filed quarter, fiscal Q4 2024, shows revenue of $2.6 million and a net loss of $2.4 million, a -91.84% margin. That is not a business earning its cost of capital; it is a business still trying to prove its model. The FairStock calculations at the $1.68 close on 2026-10-16 show P/E -0.01 and P/B 2.40, so there are no earnings to value and the price is not supported by a low book multiple. The Piotroski F-Score of 3/9 and Altman Z-Score of -1.22 point to weak financial health and some distress risk. No revenue-growth or profit-growth figures are available, and the Lynch category is none because only 0 years of filed results exist; the rules need 3. The 52-week range of $1.50 to $23.22 shows how far the shares have fallen, but a low price alone is not a margin of safety. On quality, I see no evidence of a durable moat: the technology may be promising, but ingredient markets are competitive and capital-intensive. Growth is possible from a small revenue base, yet it must come with better margins and cash discipline. Until the company shows sustained profits and a stronger balance sheet, I would call this speculative rather than a Graham-style bargain.

In plain English: The company makes ingredients for food and animal feed using plants and fermentation. It is not yet profitable: in fiscal Q4 2024 it had $2.6 million in revenue and a $2.4 million net loss, with a negative margin of about 92%. At $1.68 per share, the price does not look clearly cheap relative to the company's accounting value, and the business still looks weak based on the numbers given.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-16 close · note generated 2026-10-20 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer